In a significant advance for the treatment of obesity, biotech giant Eli Lilly has announced the results from a trial of retatrutide, which produced a staggering 24.2% weight loss in patients.
Obesity, defined as a body mass index (BMI) of 30 or higher, is a major health issue that has increased significantly over the years. As of today, it affects over 42% of adults in the United States, with 20% of children and adolescents also affected. Worldwide, more than 1 billion people are dealing with the condition, including 650 million adults, 340 million adolescents, and 39 million children.
Leave a reply